140 results on '"Chua, Chee Wai"'
Search Results
2. Featuring the guest editors for the Special Issue on Prostate Cancer, Cancer Letters
3. Modeling prostate cancer: What does it take to build an ideal tumor model?
4. Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
5. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
6. An Organoid Assay for Long-Term Maintenance and Propagation of Mouse Prostate Luminal Epithelial Progenitors and Cancer Cells
7. Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework
8. Table S4 from OncoLoop: A Network-Based Precision Cancer Medicine Framework
9. Index of Supplementary Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework
10. Detailed Materials and Methods from OncoLoop: A Network-Based Precision Cancer Medicine Framework
11. Supplementary Figures S1-S11 from OncoLoop: A Network-Based Precision Cancer Medicine Framework
12. Supplementary Video 3 from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
13. Supplementary Procedures from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
14. Supplementary Video 4 from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
15. Data from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
16. Supplementary Figures, Tables, and Legends from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
17. Supplementary Data from Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform
18. Supplementary Video 2 from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
19. Supplementary Dataset from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
20. Supplementary Video 1 from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
21. Supplementary Figure S1 from Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
22. OncoLoop: A Network-Based Precision Cancer Medicine Framework
23. TP53 loss‐of‐function causes vulnerability to autophagy inhibition in aggressive prostate cancer
24. GENETIC MUTATIONS IN PATIENT-DERIVED BLADDER TUMOR ORGANOIDS MIMIC PARENTAL TUMOR SAMPLES: PD38-07
25. Nkx3.1 controls the DNA repair response in the mouse prostate
26. Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression
27. Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer
28. Significance of TWIST expression and its association with E-cadherin in bladder cancer
29. Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases
30. Outcomes in patients with early stage uterine clear cell carcinoma treated with chemotherapy and radiotherapy: A systematic review and meta-analysis
31. Single-cell analysis supports a luminal-neuroendocrine trans-differentiation in human prostate cancer
32. Differential expression of MSX2 in nodular hyperplasia, high-grade prostatic intraepithelial neoplasia and prostate adenocarcinoma
33. TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction
34. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer
35. FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer
36. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF)
37. Outcomes in patients with early stage uterine clear cell carcinoma treated with chemotherapy and radiotherapy: A systematic review and meta-analysis
38. Identification of a basal stem cell subpopulation in the prostate via functional, lineage tracing and single-cell RNA-seq analyses
39. Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation
40. Author response: Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation
41. PD38-07 GENETIC MUTATIONS IN PATIENT-DERIVED BLADDER TUMOR ORGANOIDS MIMIC PARENTAL TUMOR SAMPLES
42. Nkx3.1 controls the DNA repair response in the mouse prostate
43. Abstract 3729: An individualized approach to bladder cancer treatment using patient-derived cell lines to predict response to chemotherapeutic agents
44. Culture of mouse prostate organoids
45. Single luminal epithelial progenitors can generate prostate organoids in culture
46. Epithelial cell lineage specification during prostate organogenesis and regeneration (210.4)
47. Garlic-derived S-allylmercaptocysteine Is a novel In vivo antimetastatic agent for androgen-independent prostate cancer
48. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion
49. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target
50. FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.